🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the EU / 2025-523135-19-00
Authorised Phase I

A study in healthy men to test how itraconazole influences the amount of BI 764198 in the blood

2025-523135-19-00 · tracked via the Priya Life Science EU tracker
Sponsor
Boehringer Ingelheim International GmbH
Sponsor type
Pharmaceutical company
Therapeutic area
Not possible to specify
Decision date
16/12/2025
Enrollment target
14
Sites
Germany

Condition studied

Healthy volunteer trial

Eligibility

Age group
18-64 years
Sex
Male
Official registry record

This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View 2025-523135-19-00 on CTIS ↗ ← All trials in the EU